T hrough the art of synthesis, chemists build simplified models to understand how information encoded in molecules can be used to control chemical processes [1] [2] [3] . One example of this in nature is the ribosome [4] [5] [6] , which recognizes a specific start codon in the mRNA strand and catalyses the sequential synthesis of a peptide in the N to C direction (Fig. 1a) 7 . This flow of sequence-specific information is encoded by sets of nucleic acids 8 . In a study in supramolecular chemistry, Leigh and co-workers synthesized an artificial small-molecule machine that synthesizes polypeptides with directionality 9 . This machine features a stoichiometric amount of thiol that moves along the rotaxane to construct a hexapeptide in the C to N direction (Fig. 1b) . In contrast, herein we describe a rhodium catalyst that promotes a cascade reduction to construct a cyclic peptide in the C to N direction. This catalyst can recognize information encoded in a sequence of prochiral units to create a cyclic peptide via hydrogenation, with excellent levels of stereocontrol (Fig. 1c) . On the basis of combined experimental and theoretical studies, we provide evidence for a unique mechanism that involves unidirectional reduction to set four stereocentres around the macrocyclic ring. Our study also provides a blueprint for using cascade catalysis 10 in building cyclic peptides.
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Cyclic peptides have attracted attention as therapeutics 11, 12 due to their enhanced metabolic stability, 13 conformational rigidity 14 and potential to mimic protein− protein interactions 15 . As a result, these circular structures continue to inspire the invention of synthetic tools and strategies 16 . The classic approach relies on coupling chiral enantiopure amino acid building blocks to generate a linear peptide prior to ring closing 17 . However, valuable enantiopure linear peptides are often affected at the macrocyclization step and suffer from C-terminal epimerization and competing oligomerization 18 . In contrast, we imagined first constructing a dehydropeptide using achiral building blocks. On the basis of previous studies, this linear dehydropeptide should readily ring close to generate a macrocycle more efficiently than its saturated counterpart 19 . In addition to the advantage of efficient ring closing, a transition metal catalyst could be used to achieve a unidirectional cascade hydrogenation to furnish the requisite stereogenic centres in a single step.
Results and discussion
In accordance with this blueprint, we prepared the linear pentapeptide 4 , which contains four dehydrophenylalanines (Δ Phe), from oxazolone 1 using a modified version of Bergmann's peptide synthesis 20 . The two-step peptide elongation involves the isolable oxazolone 1 as an activated form of carboxylic acid, which could ring open in the presence of an amine nucleophile such as racemic β -phenylserine to form 2. Then, the resulting peptide was activated with sodium acetate and acetic anhydride to afford an elongated oxazolone 3 (Fig. 2a) . After these iterations, we obtained the linear pentapeptide 4 in 53% yield over six steps. After deprotection of the linear precursor 4 using trifluoroacetic acid (TFA), 4-dimethylaminopyridine (DMAP) was added as a nucleophilic catalyst to facilitate aminolysis to afford the corresponding cyclic dehydropeptide 5a in 81% yield over two steps with no dimerization observed, despite the relatively high concentration (0.1 M) (Fig. 2b) .
To provide a more convenient handle for NMR analysis, we also prepared the fluorinated analogue 5a′ (Supplementary Information). Given that there are four dehydroamino acid residues in 5a′ , a full reduction could generate a total of 16 possible stereoisomers. Surprisingly, when a combination of [Rh(cod) 2 ]BF 4 (cod, 1,5-cyclooctadiene) and an achiral ligand (1,3-bis(diphenylphosphino)propane (dppp)) was used as a catalyst, one diastereomer was formed in 88% yield and with excellent diastereocontrol (20:2:1:1:1 d.r.) (Fig. 3, right) . Through independent synthesis from d-and l-phenylalanine, we confirmed that this isomer was (± )-cyclic d,l-α -peptide 6a′ . Of note, cyclic d,l-α -peptides have been used as therapeutic agents against gramnegative and gram-positive bacteria 21, 22 . In stark contrast, Pd/C produced a racemic mixture of all eight possible diastereomers ((± )-6a′-6h′), which were detected by 19 F-NMR spectroscopy ( Supplementary Fig. 5 ).
The Rh-catalysed hydrogenation of enamides is an irreversible process 23 . Thus, the essentially complete diastereoselectivity observed in the presence of a simple achiral ligand (that is, dppp) suggests that perhaps this reduction proceeds in a specific order about the macrocyclic ring and is controlled by the sequence of the substrate. This observation, in turn, implies that the hydrogenation is initiated by recognition of the Rh catalyst to a specific Δ Phe. To understand this intriguing finding, we performed further experimental and theoretical studies of the mechanism. First, we tested the hypothesis of a strictly sequential reduction. If the hydrogenation proceeds in one direction around the ring starting with a specific Δ Phe (I, Fig. 4a ), three intermediate macrocycles would arise (such as (± )-5b′ , (± )-5c′ and (± )-5d′ . By stopping the reduction of cyclic peptide 5a′ at various time points, three distinct intermediates were observed by 19 F NMR spectroscopy. Next, we independently prepared and characterized cyclic peptides 5b′ , 5c′ and 5d′ . The spectroscopic data for these three structures matched the structure of the aforementioned intermediates by 19 F NMR spectroscopy. Moreover, when intermediate 5b ′ was subjected to the Rh-catalysed hydrogenation conditions, the corresponding cyclic peptide 6a′ was obtained in 76% yield and 20:< 1:< 1:< 1:< 1 d.r. (Fig. 4b) . Similarly, when we subjected cyclic peptide 5c′ to hydrogenation, we also observed cyclic peptide 6a′ in 99% yield and 20:< 1:< 1:< 1:< 1 d.r. Finally, hydrogenating cyclic peptide 5d′ gave the desired peptide in 99% yield and 20:< 1:< 1:< 1:< 1 d.r. Together, these experiments support the proposed intermediates that arise during a sequential reduction that occurs with a high anti diastereoselectivity.
Next, we studied the structural origin of the experimentally observed anti selectivity through theoretical studies. Given the complexity of cyclic dehydropeptide 5a (Fig. 2) , even a minimal conformational analysis of the transition state is not feasible. We therefore used the transition-state force field for the Rh-catalysed hydrogenation of enamides 24 , which we developed previously using the quantum-guided molecular mechanics (Q2MM) method 25 . This method was previously shown to allow the rapid exploration of the conformational space at the transition state using Monte Carlo sampling and, by Boltzmann averaging of the relative energies of the conformational ensembles of the diastereomeric transition structures, to predict accurately the stereochemistry of the hydrogenation 26 . Figure 5 summarizes the results of these simulations for cyclic dehydropeptide 5a using [Rh(dppp)]
+
. Figure 5a ,b shows the lowest-energy transition structures 7 a ‡ and 7 s ‡ for the hydrogenation of cyclic dehydropeptide 5b that leads to the anti (left) and syn (right) diastereoselectivity, respectively. The accessible conformational space of the cyclic dehydropeptide is complex, and no single conformation or interaction is solely responsible for the calculated and experimentally observed preference. Nevertheless, analysis of the conformations of 7 a ‡ and 7 s ‡ shows that the side chains at Phe 1 and Δ Phe 2 are positioned in a pseudo-equatorial position to both minimize steric repulsion with the dppp ligand and maximize the π-stacking between the phenyl rings ( Supplementary Fig. 18 ), and thus the backbone of the cyclic dehydropeptide is distorted into a strained conformation. As a result, one amide bond in 7 s ‡ is forced into an energetically unfavourable 27 cis conformation (highlighted in green in Fig. 5b) , which favours the transition structure that leads to the observed anti selective hydrogenation. Clustering of the lowenergy transition structures also shows that the transition structures for the hydrogenations at Δ Phe 3 and Δ Phe 4 that lead to the experimentally observed product are stabilized by more intramolecular hydrogen bonds (Supplementary Figs. 9-11) .
Moreover, after the first hydrogenation at Δ Phe 1 in cyclic dehydropeptide 5a , the subsequent reductions that occur are anti with predicted selectivities that range from 30:1 to 78:1 d.r. (Fig. 5c) , in good agreement with the experimentally observed diastereoselectivity of 20: < 1:< 1:< 1:< 1 (Figs. 3 and 4) . Notably, the final hydrogenation at Δ Phe 4 is the least selective one, which suggests that the diastereoselectivity is related to the increased flexibility of cyclic dehydropeptide 5d.
The computational studies also allow us to probe the basic hypothesis of a sequential, unidirectional hydrogenation controlled by the interplay between the substrate and Rh catalyst. Figure 5d shows the results for the expected diastereoselectivity for the second hydrogenation at the three possible centres. Only the simulations for the sequential hydrogenation at Δ Phe 2 lead to the experimentally observed result, whereas reactions at Δ Phe 3 or Δ Phe 4 would lead to significantly different or even opposing diastereoselectivities. Together, the experimental and computational results demonstrate that the Rh catalyst preferentially binds to Δ Phe 1 for the initial reduction of cyclic dehydropeptide 5a . We hypothesize that the adjacent glycine residue, which contains a sp enables the flexibility for the Rh catalyst to bind to Δ Phe 1 in a reactive conformation to initiate the sequential reduction 28 . As the hydrogenation proceeds in the C to N direction to furnish a new α -substituted stereocentre, the next Δ Phe in the sequence becomes more flexible and is hydrogenated in the subsequent step. The opposite N to C direction is disfavoured for the initial reduction because the reactive conformations of Δ Phe 4 are higher in energy than those for Δ Phe 1 ( Supplementary Fig. 22 ).
Finally, we studied the question of whether an appropriate chiral ligand can override the diastereoselectivity observed when using the Rh-dppp catalyst. Among the thousands of chiral phosphine ligands developed for asymmetric hydrogenation 29 , DuanPhos is the best for the reduction of α -(acetamido)acrylate derivatives 30 . We previously used DuanPhos to access cyclic peptides by overriding substrate bias in the synthesis of the chickweed natural product dichotomin E (ref. 19 ). With 5 mol% [Rh(cod) 2 ]BF 4 , (R,R' ,S,S')-DuanPhos gave cyclic peptide 6b in an 86% isolated yield and > 99% e.e. (Fig. 6a) . This Rh catalyst overcomes any substrate bias to generate a single stereoisomer with a 20:< 1 d.r., as observed by 19 F NMR spectroscopy (Supplementary Information). In analysing the transformation by both 19 F NMR spectroscopy and mass spectroscopy at an early timepoint, we observed the formation of only two unsaturated intermediates, which thus supports a mechanism that involves sequential reduction (Supplementary Information). Subsequently, we also synthesized cyclic dehydropeptide 8 , which contained dehydroleucine, and subjected it to the Rh-DuanPhos catalyst to afford cyclic peptide 9a in an 84% yield, > 99% e.e. and 20:< 1 d.r. (Fig. 6b) . In using the Rh-DuanPhos catalyst with our cyclic dehydropeptides, we are able to extend the cascade hydrogenation to afford access to cyclic peptides with high levels of enantio-and diastereocontrol.
Conclusion
Molecular recognition between transition metal catalysts and amino acids is a powerful strategy in organic synthesis 31 . Through our combined experimental and theoretical study, we demonstrate an example of a unidirectional hydrogenation controlled by a small synthetic peptide and Rh catalyst. The catalyst most probably dissociates from the peptide, and thus the C to N directionality in the hydrogenation is controlled by catalyst-substrate recognition, as opposed to processive mechanisms in which the catalyst remains bound to the substrate 32 . Studying the mechanism of Rh-catalysed hydrogenation has provided insights with far-reaching impact in catalysis, such as enantioselective control 33, 34 , Curtin-Hammett selectivity 23 and chiral amplification 35, 36 . In the context of hydrogenation, our report showcases an example of a sequential and stereoselective mechanism. These insights highlight the potential of molecular recognition in organic synthesis and provide a foundation for the construction of cyclic peptides by cascade catalysis 10 . Data availability. Full experimental procedures and spectral data for all the new compounds as well as computational details are included in the Supplementary Information and are available from the corresponding authors on request. Non-reacting hydrogens are hidden and phenyls on the ligand are shown transparent for clarity. a, The lowest-energy transition structure 7 a ‡ for hydrogenation at Δ Phe 2 that leads to anti diastereoselectivity. b, The lowest-energy transition structure 7 s ‡ for hydrogenation at Δ Phe 2 that leads to syn diastereoselectivity. c, The predicted selectivities for hydrogenation supports sequential reduction. d, The predicted selectivities support a second diastereoselective reduction that occurs at Δ Phe 2 , whereas a reduction that occurs at Δ Phe 3 or Δ Phe 4 would lead to a diminished diastereoselectivity. 5b = cyclo(Gly-Δ Phe-Δ Phe-Δ Phe-Phe). 
